Cancer is a malignant disease in which the cell grows abnormally due to its uncontrolled division. It is one of the maladies with the highest prevalence rate globally. It is also one of the main causes of death in the world, despite the new technologies and treatments used. Cancer, as a disease, has been under treatment for so many years due to its high occurrence rate (Chandraprasad, Dey, & Swamy, 2022). Different techniques are used for its treatment as the research criteria expand to find the cure. Many medicines and several therapies are used, yet so many more are under experimentation for the treatment of cancer. These include the blend of chemotherapy, radiation therapy, and some targeted drug delivery therapies (Jin, Wang, & Bernards, 2023). Proteomics and genomics play an important role in uncovering how to treat cancer. Great progress has been made to develop new technologies and different therapeutic agents to treat cancer (Kwon et al., 2021). One of these significant technologies to treat cancer is nanotechnology.Nanotechnology is a branch of biotechnology that deals with the study of performance and use of technology on a nano-scale. At the nano-scale, nanoparticles that are the size of 1nm to 1000nm are used. These nanoparticles are ultrafine, nano-sized particles with newfound optical, primary, and electronic-structural properties (R. Sharma, Sharma, & Kumar, 2022). Nanotechnology can provide an autoimmune alternative for the lives of cancer patients by improving their quality and expectancy (Sahu et al., 2021). Conventional chemotherapeutics and radiotherapy have failed to provide efficient cancer treatments, so nano-therapeutics play a pivotal role in enhancing cancer treatment (Bukhari, 2022). Nano-therapeutics are efficiently working as novel delivery systems for targeted drug delivery in cancer (L. Zhou et al., 2022).